Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial investigating relationships between functional connectivity and amyloid deposition in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update assessing safety and efficacy of AADvac1 in patients with mild Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Detecting an Early Response to Donepezil With Measures of Visual Attention [Phase 4]
Phase 4 trial updating on detecting early response to donepezil using measures of visual attention in Alzheimer disease.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease [Phase 4]
Phase 4 clinical trial update for Nuedexta in treating pseudobulbar affect in patients with Alzheimer's disease; study status terminated.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease [Phase 3]
Phase 3 clinical trial update for Octohydroaminoacridine succinate tablets in mild-to-moderate Alzheimer's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061) [Phase 3]
Phase 3 trial assessing safety and efficacy of suvorexant for insomnia in individuals with Alzheimer’s disease has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study [EARLY_Phase 1]
Proof-of-concept Phase 1 trial evaluating valproic acid in subjects with intact cognition related to Alzheimer's disease; trial completed wi…
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD) [Phase 1]
Phase 1 trial update for LY2599666 in healthy participants and individuals with mild cognitive impairment or Alzheimer's disease; study term…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: A Safety Study of LY2886721 Single Doses in Healthy Subjects [Phase 1]
Phase 1 safety study of a single dose of LY2886721 in healthy subjects completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. [Phase 4]
A Phase 4 study evaluating safety, efficacy, and tolerability of rivastigmine patch in patients with mild to moderate Alzheimer's disease ha…
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Age-related Hearing Loss and Lexical Disorders
A completed clinical trial investigated the relationship between age-related hearing loss (presbycusis) and lexical-language disorders in th…
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Cerebral and Peripheral Perfusion Pilot Study [Phase 2]
Phase 2 clinical trial update for a perfusion pilot study in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum [Phase 2]
An extension Phase 2 study evaluating the long-term safety and tolerability of JNJ-54861911 in participants with early Alzheimer's disease. …
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia [Phase 4]
Phase 4 trial update on repetitive transcranial magnetic stimulation for apathy in Alzheimer's dementia has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA) [Phase 2]
A Phase 2 study investigating DHP1401 in patients with mild-to-moderate Alzheimer's disease treated with donepezil has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia) [NA]
A completed clinical trial investigating photobiomodulation for improving brain function in dementia, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease [Phase 2]
Phase IIa study assessing 18F-FDG PET, safety, and tolerability of AZD0530 in mild Alzheimer's disease completed with results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease [Phase 2]
Phase 2 trial investigating statin effects on beta-amyloid and cerebral perfusion in adults at risk for Alzheimer's disease; completed with …
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease [Phase 2, Phase 3]
Clinical trial update reporting on the efficacy of Ginkgo Biloba Extract for Alzheimer's disease across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease [Phase 2, Phase 3]
A clinical trial update for lanabecestat in early Alzheimer's disease shows the study conduct with termination and posted results.
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia [Phase 3]
Phase 3 trial of lanabecestat in mild Alzheimer's disease dementia terminated.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: A Safety and Tolerability Study of GB301 [Phase 1, Phase 2]
A safety and tolerability study of GB301 in Alzheimer disease across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease [Phase 2, Phase 3]
Phase 2/3 trial evaluating albumin and immunoglobulin in Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Endothelial Facilitation in Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial on endothelial facilitation for Alzheimer's disease has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease [Phase 1]
Phase 1 trial update for LY2886721 in healthy participants and individuals with Alzheimer disease; results posted after completion.